Isolagen reports progress in nasolabial-fold therapy trials

February 5, 2008

Exton, Pa. - Biotech company Isolagen announced recently that injections have been completed in the phase 3 clinical trials evaluating the Isolagen Therapy for the treatment of nasolabial folds, and that trial subjects are now in the follow-up period, PRNewswire reports.

Exton, Pa. - Biotech company Isolagen announced recently that injections have been completed in the phase 3 clinical trials evaluating the Isolagen Therapy for the treatment of nasolabial folds, and that trial subjects are now in the follow-up period, PRNewswire reports.

Isolagen also announced the completion of injections in the phase 2 open-label study, which is gathering further safety and application information on the use of the Isolagen Therapy.